Daniel W. Kulp

9.1k total citations
43 papers, 2.9k citations indexed

About

Daniel W. Kulp is a scholar working on Molecular Biology, Immunology and Virology. According to data from OpenAlex, Daniel W. Kulp has authored 43 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 20 papers in Immunology and 10 papers in Virology. Recurrent topics in Daniel W. Kulp's work include Immunotherapy and Immune Responses (12 papers), HIV Research and Treatment (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Daniel W. Kulp is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), HIV Research and Treatment (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Daniel W. Kulp collaborates with scholars based in United States, United Kingdom and Germany. Daniel W. Kulp's co-authors include William R. Schief, William F. DeGrado, Jason E. Donald, Sergey Menis, Dennis R. Burton, Devin Sok, Bryan Briney, Oleksandr Kalyuzhniy, Matthias Pauthner and Takayuki Ota and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Daniel W. Kulp

40 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel W. Kulp United States 25 1.6k 922 809 493 448 43 2.9k
Mathias Viard United States 33 1.9k 1.2× 612 0.7× 825 1.0× 512 1.0× 157 0.4× 70 2.9k
Marzena Pazgier United States 34 2.1k 1.3× 1.2k 1.3× 822 1.0× 397 0.8× 570 1.3× 103 3.9k
Michael S. Kay United States 24 1.5k 1.0× 233 0.3× 728 0.9× 610 1.2× 312 0.7× 49 2.4k
V.N. Malashkevich United States 34 2.4k 1.5× 423 0.5× 557 0.7× 673 1.4× 293 0.7× 65 4.1k
Katie J. Doores United Kingdom 32 1.6k 1.0× 866 0.9× 1.4k 1.7× 931 1.9× 691 1.5× 78 3.3k
Ponraj Prabakaran United States 24 860 0.5× 461 0.5× 359 0.4× 698 1.4× 757 1.7× 63 2.0k
Jonathan M. Gershoni Israel 30 2.6k 1.7× 686 0.7× 508 0.6× 357 0.7× 1.1k 2.5× 87 4.1k
Natalia de Val United States 32 2.1k 1.3× 1.1k 1.2× 2.3k 2.8× 914 1.9× 964 2.2× 56 3.9k
H. Feinberg United States 23 1.5k 1.0× 1.3k 1.4× 245 0.3× 272 0.6× 351 0.8× 38 2.6k
Yong Xiong United States 44 4.0k 2.5× 797 0.9× 1.1k 1.4× 730 1.5× 115 0.3× 151 5.8k

Countries citing papers authored by Daniel W. Kulp

Since Specialization
Citations

This map shows the geographic impact of Daniel W. Kulp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel W. Kulp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel W. Kulp more than expected).

Fields of papers citing papers by Daniel W. Kulp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel W. Kulp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel W. Kulp. The network helps show where Daniel W. Kulp may publish in the future.

Co-authorship network of co-authors of Daniel W. Kulp

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel W. Kulp. A scholar is included among the top collaborators of Daniel W. Kulp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel W. Kulp. Daniel W. Kulp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Xizhou, Pratik Bhojnagarwala, Kevin Liaw, et al.. (2025). Structural engineering of stabilized, expanded epitope nanoparticle vaccines for HPV. Frontiers in Immunology. 16. 1535261–1535261.
2.
Garcia, Marco, et al.. (2024). Involvement of ArlI, ArlJ, and CirA in archaeal type IV pilin-mediated motility regulation. Journal of Bacteriology. 206(6). e0008924–e0008924. 2 indexed citations
3.
Chu, Jacqueline D., E. Gary, Elizabeth M. Parzych, et al.. (2024). Structure and sequence engineering approaches to improve in vivo expression of nucleic acid-delivered antibodies. Molecular Therapy. 33(1). 152–167.
4.
O’Connell, Ryan P., Kevin Liaw, Nils Wellhausen, et al.. (2024). Format-tuning of in vivo-launched bispecific T cell engager enhances efficacy against renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 12(6). e008733–e008733. 6 indexed citations
5.
Adolf‐Bryfogle, Jared, Jason W. Labonte, John C. Kraft, et al.. (2024). Growing Glycans in Rosetta: Accurate de novo glycan modeling, density fitting, and rational sequon design. PLoS Computational Biology. 20(6). e1011895–e1011895. 8 indexed citations
6.
Andrade, Viviane M., et al.. (2023). Delineation of DNA and mRNA COVID-19 vaccine-induced immune responses in preclinical animal models. Human Vaccines & Immunotherapeutics. 19(3). 2281733–2281733. 5 indexed citations
7.
Tursi, Nicholas J., Ziyang Xu, Susanne N. Walker, et al.. (2023). Engineered antibody cytokine chimera synergizes with DNA-launched nanoparticle vaccines to potentiate melanoma suppression in vivo. Frontiers in Immunology. 14. 1072810–1072810. 3 indexed citations
8.
Bordoloi, Devivasha, Pratik Bhojnagarwala, Alfredo Perales‐Puchalt, et al.. (2022). A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapy. JCI Insight. 7(22). 14 indexed citations
9.
Walker, Susanne N., Neethu Chokkalingam, Emma L. Reuschel, et al.. (2020). SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients. Journal of Clinical Microbiology. 58(11). 42 indexed citations
10.
Xu, Ziyang, Neethu Chokkalingam, Edgar Tello‐Ruiz, et al.. (2020). A DNA-Launched Nanoparticle Vaccine Elicits CD8+ T-cell Immunity to Promote In Vivo Tumor Control. Cancer Immunology Research. 8(11). 1354–1364. 21 indexed citations
11.
Tokatlian, Talar, Benjamin J. Read, Christopher A. Jones, et al.. (2018). Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers. Science. 363(6427). 649–654. 212 indexed citations
12.
Tokatlian, Talar, Daniel W. Kulp, Christopher A. Jones, et al.. (2018). Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes. Scientific Reports. 8(1). 16527–16527. 62 indexed citations
13.
Crooks, Ema T., Keiko Osawa, Tommy R. Tong, et al.. (2017). Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody induction. Virology. 505. 193–209. 24 indexed citations
14.
Abbott, Robert, Jeong Hyun Lee, Sergey Menis, et al.. (2017). Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens. Immunity. 48(1). 133–146.e6. 204 indexed citations
15.
Sok, Devin, Bryan Briney, Joseph G. Jardine, et al.. (2016). Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice. Science. 353(6307). 1557–1560. 109 indexed citations
16.
Zhang, Shaoqing, Daniel W. Kulp, Chaim A. Schramm, et al.. (2015). The Membrane- and Soluble-Protein Helix-Helix Interactome: Similar Geometry via Different Interactions. Structure. 23(3). 527–541. 62 indexed citations
17.
Bates, John T., Christopher J. Keefer, James C. Slaughter, et al.. (2014). Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein. Virology. 454-455. 139–144. 32 indexed citations
18.
Kulp, Daniel W. & William R. Schief. (2013). Advances in structure-based vaccine design. Current Opinion in Virology. 3(3). 322–331. 79 indexed citations
19.
Pires, Marcos M., Yibing Wu, Hyunil Jo, et al.. (2012). Alteration of the oxygen-dependent reactivity of de novo Due Ferri proteins. Nature Chemistry. 4(11). 900–906. 112 indexed citations
20.
Kulp, Daniel W., Paul C. Billings, Sungwook Choi, et al.. (2009). Small-molecule inhibitors of integrin α 2 β 1 that prevent pathological thrombus formation via an allosteric mechanism. Proceedings of the National Academy of Sciences. 106(3). 719–724. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mathias Viard Breakdown of academic impact, for papers by Marzena Pazgier Breakdown of academic impact, for papers by Michael S. Kay Breakdown of academic impact, for papers by V.N. Malashkevich Breakdown of academic impact, for papers by Katie J. Doores Breakdown of academic impact, for papers by Ponraj Prabakaran Breakdown of academic impact, for papers by Jonathan M. Gershoni Breakdown of academic impact, for papers by Natalia de Val Breakdown of academic impact, for papers by H. Feinberg Breakdown of academic impact, for papers by Yong Xiong
Rankless by CCL
2026